Solution Phase Conformation and Proteolytic Stability of Amide-Linked Neuraminic Acid Analogues

ABSTRACT Amide‐linked homopolymers of sialic acid offer the advantages of stable secondary structure and increased bioavailability making them useful constructs for pharmaceutical design and drug delivery. Defining the structural characteristics that give rise to secondary structure in aqueous solut...

Full description

Saved in:
Bibliographic Details
Published inBiopolymers Vol. 99; no. 10; pp. 686 - 696
Main Authors Saludes, Jonel P., Gregar, Travis Q., Monreal, I. Abrrey, Cook, Brandan M., Danan-Leon, Lieza M., Gervay-Hague, Jacquelyn
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.10.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:ABSTRACT Amide‐linked homopolymers of sialic acid offer the advantages of stable secondary structure and increased bioavailability making them useful constructs for pharmaceutical design and drug delivery. Defining the structural characteristics that give rise to secondary structure in aqueous solution is challenging in homopolymeric material due to spectral overlap in NMR spectra. Having previously developed computational tools for heteroologomers with resolved spectra, we now report that application of these methods in combination with circular dichroism, NH/ND NMR exchange rates and nOe data has enabled the structural determination of a neutral, δ‐amide‐linked homopolymer of a sialic acid analogue called Neu2en. The results show that the inherent planarity of the pyranose ring in Neu2en brought about by the α,δ‐conjugated amide bond serves as the primary driving force of the overall conformation of the homooligomer. This peptide surrogate has an excellent bioavailability profile, with half‐life of ∼12 h in human blood serum, which offers a viable peptide scaffold that is resistant to proteolytic degradation. Furthermore, a proof‐of‐principle study illustrates that Neu2en oligomers are functionalizable with small molecule ligands using 1,3‐dipolar cycloaddition chemistry. © 2013 Wiley Periodicals, Inc. Biopolymers 99: 686–696, 2013.
Bibliography:Washington State University Startup; University of Arizona; Murdock Charitable Trust
ark:/67375/WNG-LF199KS4-6
NSF - No. CHE-0518010; CHE-0196482; CHE-0443516; DBI-0722538; OSTI 97-24412; CHE-9115282; DBI-9604689
istex:8C2AEB4BE4DCF7AF96B4FBE60E95E1426DF87066
ArticleID:BIP22315
NIH - No. RR11973; RR0631401; RR12948
This article was originally published online as an accepted preprint. The “Published Online” date corresponds to the preprint version. You can request a copy of the preprint by emailing the Biopolymers editorial office at
biopolymers@wiley.com
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Current address: 3M, 3M Center, St. Paul, Minnesota 55144
Current address: Sutro Biopharma Inc., South San Francisco, California 94080
ISSN:0006-3525
1097-0282
DOI:10.1002/bip.22315